Drug development in neurology has typically been more successful than cancer, but this has not been the case when trying to develop treatments for Alzheimer’s. Perhaps Alzheimer programs should look at recent innovations in oncology clinical trials for inspiration. Read more
Adoption of adaptive designs in clinical trials has been particularly slow in oncology, in part because clinical endpoints in cancer tend to be long-term, and this means that few patients will experience an endpoint in the early stages of a trial and so be able to help direct its course. Click here to read how the [...]
Adaptive designs for clinical trials are being used increasingly in many areas of medical research. An adaptive design differs from a traditional design in … http://jco.ascopubs.org/content/29/6/606.full
© Copyright 2012 Tessella plc | Sitemap